Opinion

Video

Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

Author(s):

Elizabeth R. Plimack, MD, MS, FASCO,Neeraj Agarwal, MD

Experts on muscle-invasive bladder cancer respond to recent data in adjuvant therapy that were presented at ASCO GU 2024.

Related Videos
Neil Iyengar, MD, and Chandler Park, MD, FACP
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Tiago Biachi, MD, PhD
Related Content
Multiple Myeloma | stock.adobe.com
December 19th 2024

New Protocol Reduces Adverse Effects In Use of Key Drug for Multiple Myeloma

Mazyar Shadman, MD, MPH, associate professor, Clinical Research Division, medical director, Cellular Immunotherapy, Fred Hutchinson Cancer Center
December 19th 2024

Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH

Fellows of the American College of Surgeons | Image Credit: © Katsyarina - stock.adobe.com
December 4th 2024

Fox Chase Cancer Center’s Dr. Anthony M. Villano and Dr. Austin D. Williams Named Fellows of the American College of Surgeons

Oncology Unplugged
November 6th 2024

Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD

ALLO-316 in Advanced CD70-Positive ccRCC | Image Credit: © Cornflakesei - stock.adobe.com
November 27th 2024

ALLO-316 Demonstrates Early Activity and Safety in Advanced CD70-Positive ccRCC

Chelsey Schlechter, MPH, PhD
November 27th 2024

Dr Schlechter Named Cancer Moonshot Scholar